A Five-Gene Risk Score Model for Predicting the Prognosis of Multiple Myeloma Patients Based on Gene Expression Profiles
Multiple myeloma is a heterogeneous plasma cell malignancy that remains incurable because of the tendency of relapse for most patients. Survival outcomes may vary widely due to patient and disease variables; therefore, it is necessary to establish a more accurate prognostic model to improve prognost...
Guardado en:
Autores principales: | Xiaotong Chen, Lintao Liu, Mengping Chen, Jing Xiang, Yike Wan, Xin Li, Jinxing Jiang, Jian Hou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60180c643933496c808c7541fc404078 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
por: Shuang Liu, et al.
Publicado: (2021) -
Mieloma múltiple en Chile: Características clínicas y sobrevida
por: Conté L,Guillermo, et al.
Publicado: (2007) -
Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens
por: Paweł Robak, et al.
Publicado: (2021) -
Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study
por: Shebli ATRASH, et al.
Publicado: (2021) -
The outcome of young vs. old gastric cancer patients following gastrectomy: a propensity score matching analysis
por: Yu-Xi Cheng, et al.
Publicado: (2021)